Search results
New York State Common Retirement Fund Acquires 2,082 Shares of Sana Biotechnology, Inc....
ETF DAILY NEWS· 4 days agoNew York State Common Retirement Fund boosted its holdings in shares of Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 5.4% in the 4th quarter, according to the company ...
EPA, FDA, and USDA Issue Joint Regulatory Plan for Biotechnology
The National Law Review· 6 days agoFood and Drug Administration (FDA), and the U.S. Department of Agriculture (USDA) released a plan to...
Independent Advisor Alliance Sells 79 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)
ETF DAILY NEWS· 20 hours ago:AXON – Free Report) by 3.6% in the 4th quarter, according to the company in its most recent...
Brokerages Set United Therapeutics Co. (NASDAQ:UTHR) Price Target at $308.78
ETF DAILY NEWS· 4 hours agoShares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) have earned an average recommendation of “Moderate Buy” from the ten ratings firms that are covering the stock, MarketBeat.com ...
Earnings call: BiomX reports Q1 2024 results, optimistic on phage therapies By Investing.com
Investing.com· 14 hours agoBiomX Inc. (NYSE: NYSE:PHGE), a biotechnology company specializing in phage-based therapies, has...
How to get a job in biotech without going to college
GBH News· 1 day agoElla Show was a good student who loved science but in her senior year of high school, she decided to skip college. Show joined a tuition free program at...
HC Wainwright Reaffirms “Buy” Rating for Unity Biotechnology (NASDAQ:UBX)
ETF DAILY NEWS· 4 days agoHC Wainwright reiterated their buy rating on shares of Unity Biotechnology (NASDAQ:UBX – Free Report) in a research note released on Wednesday morning, Benzinga reports. The ...
MAIA Biotechnology Inc (MAIA) Shares Plummet Below 1-Year High – News Heater
NewsHeater· 7 days agoMAIA Biotechnology Inc (AMEX: MAIA)’s stock price has gone decline by -6.89 in comparison to its previous close of 3.05, however, the company has experienced a -15.48% decrease ...
BIO to restructure, lay off staff in shakeup of lobbying group
BioPharma Dive via Yahoo Finance· 2 days agoThe Biotechnology Innovation Organization is restructuring after conducting a “thorough evaluation”...
Eupraxia Pharmaceuticals Announces New Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI for...
WROC Rochester· 9 hours agoEupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a...